Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study

NCT01689389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2292

Last updated 2015-12-15

No results posted yet for this study

Summary

The aim of the study is to describe patient characteristics (demographic and clinical) and the patterns of use of Quetiapine XR in patients receiving the drug for the first time in real-life practice regardless the final diagnosis.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Bruno FALISSARD, Pr · Paris

  • Pierre-Michel LLORCA, Pr · Clermont-Ferrand

Eligibility

Min Age
18 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01689389 on ClinicalTrials.gov